Skip to content
i2o Therapeutics logo — Boston-based biotech startup developing novel biologic thera...

i2o Therapeutics

Boston-based biotech startup developing novel biologic therapies

Founded 2019 United States Cambridge, United States 13 employees Series A Biotechnology, Health Care +1

General Information

Company Name i2o Therapeutics
Founded Year 2019
Location United States Cambridge, United States
Employees 13
Industries Biotechnology, Health Care, Health and Wellness
Funding Stage Series A
Social

BounceWatch is an independent company data service, not affiliated with i2o Therapeutics. To contact i2o Therapeutics, visit i2obio.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does i2o Therapeutics compare?

A PDF of i2o Therapeutics and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting i2o Therapeutics soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About i2o Therapeutics

is a Boston-based biotech startup that is dedicated to developing next generation biologic therapies. The company, founded in 2019, operates in the industries of biotechnology, health care, and health and wellness. Recently, on 28 August 2023, i2o Therapeutics received a significant boost with a Series A investment. The investors participating in this round remain undisclosed at present. With its focus on pioneering biologic therapies, i2o Therapeutics is poised to make a significant impact in the biotech sector from its headquarters in the United States.

Business keywords: biotech, therapeutics, oral formulations, ionic liquid technology, drug delivery, peptide-based therapies, protein-based therapies, innovation, biologic treatments, startup, biopharmaceuticals, drug administration, innovative therapies

Funding Rounds & Investors (6)

View All
Funding Stage Amount Investors Lead Investors Date
Series A Undisclosed -
28 Aug 2023
Venture Series Unknown Undisclosed -
11 Oct 2022
Debt Financing Undisclosed -
24 Jan 2022
Debt Financing Undisclosed -
16 Nov 2020
Debt Financing Undisclosed -
23 Mar 2020
Debt Financing Undisclosed -
27 Jun 2019

i2o Therapeutics Alternatives & Competitors

View All Alternatives
i2o Therapeutics vs

Dedicated to developing effective and novel targeted treatments for cancer.

Grant
12 employees
Biopharma, Biotechnology
i2o Therapeutics vs

We are committed to developing transformational biologic medicines to serve patients with debilitati...

Post-IPO Equity
17 employees
Biotechnology, Health and Wellness
i2o Therapeutics vs
Rani Therapeutics
Rani Therapeutics United States

Making Oral Biologics a Reality.

Post-IPO Equity
96 employees
Biotechnology, Health and Wellness

FAQ About i2o Therapeutics

Boston-based biotech startup developing novel biologic therapies
i2o Therapeutics was founded in 2019.
i2o Therapeutics is headquartered in Cambridge, United States.
i2o Therapeutics operates in Biotechnology, Health Care and Health and Wellness. Its work centres on biotech, therapeutics, oral formulations and ionic liquid technology.
i2o Therapeutics has approximately 13 employees.
i2o Therapeutics has completed 6 funding rounds. The latest funding stage is Series A.
Top alternatives and competitors to i2o Therapeutics include Soricimed Biopharma Inc., Applied Molecular Transport, Rani Therapeutics, Nanotransfer, Lindy Biosciences, Inc.. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
i2o Therapeutics and Soricimed Biopharma Inc. are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for i2o Therapeutics, https://bouncewatch.com/company/i2o-therapeutics, updated 8 January 2025. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout